Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

HOLX – Hologic, Inc.

Float Short %

2

Margin Of Safety %

22

Put/Call OI Ratio

0.91

EPS Next Q Diff

0.01

EPS Last/This Y

0.89

EPS This/Next Y

0.28

Price

68.25

Target Price

73.53

Analyst Recom

2.33

Performance Q

25.29

Relative Volume

0.6

Beta

0.57

Ticker: HOLX




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25HOLX66.51.110.0318644
2025-07-28HOLX65.691.020.5319472
2025-07-29HOLX66.051.020.3519468
2025-07-30HOLX651.020.9019516
2025-07-31HOLX66.831.020.0319596
2025-08-01HOLX67.150.992.9719864
2025-08-04HOLX67.90.980.5019800
2025-08-05HOLX67.850.980.2419835
2025-08-06HOLX66.890.940.0320105
2025-08-07HOLX67.940.930.0820304
2025-08-08HOLX68.070.930.0020317
2025-08-11HOLX680.922.3420349
2025-08-12HOLX67.960.940.0320524
2025-08-13HOLX690.950.0120472
2025-08-14HOLX68.070.900.0121057
2025-08-15HOLX67.840.860.0221560
2025-08-18HOLX67.260.911.5620717
2025-08-19HOLX67.820.950.2422252
2025-08-20HOLX68.760.950.8422328
2025-08-21HOLX67.150.970.0723084
2025-08-22HOLX68.250.910.6424016
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25HOLX66.50-0.8525.84.18
2025-07-28HOLX65.68-0.8502.94.18
2025-07-29HOLX66.04-0.8524.94.18
2025-07-30HOLX64.98-0.8498.24.18
2025-07-31HOLX66.826.3578.74.18
2025-08-01HOLX67.166.3548.64.18
2025-08-04HOLX67.919.0301.44.23
2025-08-05HOLX67.829.0288.24.23
2025-08-06HOLX66.889.0275.04.23
2025-08-07HOLX67.939.0305.64.23
2025-08-08HOLX68.069.1484.44.24
2025-08-11HOLX68.029.1481.34.24
2025-08-12HOLX67.979.1481.74.24
2025-08-13HOLX68.989.1500.74.24
2025-08-14HOLX68.059.1465.64.24
2025-08-15HOLX67.859.1478.34.24
2025-08-18HOLX67.259.1472.14.24
2025-08-19HOLX67.829.1492.14.24
2025-08-20HOLX68.789.1499.44.24
2025-08-21HOLX67.159.1453.44.24
2025-08-22HOLX68.259.1501.84.24
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25HOLX0.280.982.33
2025-07-28HOLX0.282.042.33
2025-07-29HOLX0.282.042.33
2025-07-30HOLX0.282.042.33
2025-07-31HOLX0.282.042.33
2025-08-01HOLX0.282.042.33
2025-08-04HOLX0.292.702.33
2025-08-05HOLX0.292.702.33
2025-08-06HOLX0.292.702.33
2025-08-07HOLX0.292.702.33
2025-08-08HOLX0.292.702.33
2025-08-11HOLX0.292.452.33
2025-08-12HOLX0.292.452.00
2025-08-13HOLX0.292.452.00
2025-08-14HOLX0.292.452.00
2025-08-15HOLX0.292.452.00
2025-08-18HOLX0.29-0.302.00
2025-08-19HOLX0.29-0.302.00
2025-08-20HOLX0.29-0.302.00
2025-08-21HOLX0.29-0.302.00
2025-08-22HOLX0.28-0.302.00
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

1.08

Avg. EPS Est. Current Quarter

1.1

Avg. EPS Est. Next Quarter

1.09

Insider Transactions

0.28

Institutional Transactions

-0.3

Beta

0.57

Average Sales Estimate Current Quarter

1034

Average Sales Estimate Next Quarter

1067

Fair Value

83.43

Quality Score

86

Growth Score

68

Sentiment Score

10

Actual DrawDown %

22.3

Max Drawdown 5-Year %

-39.9

Target Price

73.53

P/E

28.32

Forward P/E

15.12

PEG

4.15

P/S

3.76

P/B

3.13

P/Free Cash Flow

16.29

EPS

2.41

Average EPS Est. Cur. Y​

4.24

EPS Next Y. (Est.)

4.52

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.79

Relative Volume

0.6

Return on Equity vs Sector %

-13.2

Return on Equity vs Industry %

2.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.06

EBIT Estimation

501.8
Hologic, Inc.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 7063
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
stock quote shares HOLX – Hologic, Inc. Stock Price stock today
news today HOLX – Hologic, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch HOLX – Hologic, Inc. yahoo finance google finance
stock history HOLX – Hologic, Inc. invest stock market
stock prices HOLX premarket after hours
ticker HOLX fair value insiders trading